These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32710904)

  • 1. Recommendations for Enhancing Quality and Capability of Indian Biopharmaceutical Industry: Summary of a Workshop.
    Uppal A; Koduri CK; Yadlapalli S; Chirmule N; Chakrabarti R; Atouf F
    J Pharm Sci; 2020 Oct; 109(10):2958-2961. PubMed ID: 32710904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopharmaceutical Industry Capability Building in India: Report from a Symposium.
    Uppal A; Chakrabarti R; Chirmule N; Rathore A; Atouf F
    J Pharm Innov; 2022; 17(4):1555-1562. PubMed ID: 34849178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary from Advanced Manufacturing Technology Workshop Held at 6th Accelerating Biopharmaceutical Development Meeting.
    Lee KH; Mantle JL
    PDA J Pharm Sci Technol; 2021; 75(1):48-63. PubMed ID: 32540863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape.
    Moorkens E; Meuwissen N; Huys I; Declerck P; Vulto AG; Simoens S
    Front Pharmacol; 2017; 8():314. PubMed ID: 28642701
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant drug development, regulation, and commercialization: an Indian industry perspective.
    Sahoo N; Manchikanti P
    BioDrugs; 2011 Apr; 25(2):105-13. PubMed ID: 21230010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIIMBL-Facilitated Active Listening Meeting between Industry and FDA Identifies Common Challenges for Adoption of New Biopharmaceutical Manufacturing Technologies.
    Mantle JL; Lee KH
    PDA J Pharm Sci Technol; 2020; 74(5):497-508. PubMed ID: 32467179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions.
    Szkodny AC; Lee KH
    Annu Rev Chem Biomol Eng; 2022 Jun; 13():141-165. PubMed ID: 35300518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study.
    Tauqeer F; Myhr K; Gopinathan U
    Health Policy Plan; 2019 Jul; 34(6):440-449. PubMed ID: 31302684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s).
    Hu H; Chung CC
    Int J Health Policy Manag; 2015 Sep; 4(12):823-9. PubMed ID: 26673466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioprocessing in the Digital Age: The Role of Process Models.
    Narayanan H; Luna MF; von Stosch M; Cruz Bournazou MN; Polotti G; Morbidelli M; Butté A; Sokolov M
    Biotechnol J; 2020 Jan; 15(1):e1900172. PubMed ID: 31486583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosimilars: opportunity or cause for concern?
    Roger SD; Mikhail A
    J Pharm Pharm Sci; 2007; 10(3):405-10. PubMed ID: 17727803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward microfluidic continuous-flow and intelligent downstream processing of biopharmaceuticals.
    Sharma V; Mottafegh A; Joo JU; Kang JH; Wang L; Kim DP
    Lab Chip; 2024 May; 24(11):2861-2882. PubMed ID: 38751338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustainability in the biopharmaceutical industry: Seeking a holistic perspective.
    Lalor F; Fitzpatrick J; Sage C; Byrne E
    Biotechnol Adv; 2019; 37(5):698-707. PubMed ID: 30922993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D.
    Farid SS; Baron M; Stamatis C; Nie W; Coffman J
    MAbs; 2020; 12(1):1754999. PubMed ID: 32449439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. With the help of a foreign ally: biopharmaceutical innovation in India after TRIPS.
    Angeli F
    Health Policy Plan; 2014 May; 29(3):280-91. PubMed ID: 23558959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the potential of machine learning for more efficient development and production of biopharmaceuticals.
    Puranik A; Dandekar P; Jain R
    Biotechnol Prog; 2022 Nov; 38(6):e3291. PubMed ID: 35918873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyberbiosecurity in Advanced Manufacturing Models.
    Guttieres D; Stewart S; Wolfrum J; Springs SL
    Front Bioeng Biotechnol; 2019; 7():210. PubMed ID: 31552236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A QRM Discussion of Microbial Contamination of Non-sterile Drug Products, Using FDA and EMA Warning Letters Recorded between 2008 and 2016.
    Santos AMC; Doria MS; Meirinhos-Soares L; Almeida AJ; Menezes JC
    PDA J Pharm Sci Technol; 2018; 72(1):62-72. PubMed ID: 29242394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Japan-Specific Key Regulatory Aspects for Development of New Biopharmaceutical Drug Products.
    Desai KG; Obayashi H; Colandene JD; Nesta DP
    J Pharm Sci; 2018 Jul; 107(7):1773-1786. PubMed ID: 29601839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.